Ashleigh Rogers
Long/short equity, growth at reasonable price, value, banks

Gentiva Is Cheap But Still Hard To Get Excited About

Home health and hospice leader Gentiva Health Services (NASDAQ:GTIV) is fairly cheap at today's prices of roughly $10.50 a share implying a forward multiple of ~9X based on consensus adjusted EPS of $1.20 for 2014. Even so, I still have a hard time getting excited about the stock at almost any price. Gentiva has been frustratingly inconsistent on both earnings and revenue, and while it is certainly true that the regulatory environment around hospice care is finally stabilizing, I think the company still has some headwinds to face.

In particular, there is a significant probability that there will be Medicare reimbursement challenges for the company in the next year for GTIV's home health unit. Lower Medicare reimbursement rates...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details